ask="0.95"
ask_size="1000"
average_daily_volume="116175"
bid="0.67"
bid_size="800"
book_value="0.69"
change="+0.06"
change_from_200_day_moving_average="-0.45"
change_from_50_day_moving_average="-0.24"
change_from_52_week_high="-2.43"
change_From_52_week_low="0.11"
change_in_percent="+6.98%"
close="0.92"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.16"
ebitda="-17.60M"
eps_estimate_current_year="-0.82"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="6119000"
high="0.94"
high_52_weeks="3.35"
last_trade_date="3/15/2017"
last_trade_price="0.92"
last_trade_size="100"
last_trade_time="4:00pm"
low="0.85"
low_52_weeks="0.81"
market_capitalization="15.08M"
moving_average_200_day="1.37"
moving_average_50_day="1.16"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="23.00"
open="0.87"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-32.82%"
percent_change_from_50_day_moving_average="-20.45%"
percent_change_from_52_week_high="-72.54%"
percent_change_from_52_week_low="+13.58%"
previous_close="0.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.24"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.63"
stock_exchange="NGM"
symbol="ORPN"
volume="64839"
weeks_range_52="0.81 - 3.35"
